NCT00130975View on ClinicalTrials.gov

Candesartan in the Prevention of Relapsing Atrial Fibrillation

PHASE3CompletedINTERVENTIONAL

Enrollment

200

Participants

Timeline

Start Date

April 30, 2001

Study Completion Date

September 30, 2005

Conditions

Atrial Fibrillation

Interventions

DRUG

Candesartan

Trial Locations (2)

1309

Asker & Baerum Hospital, Rud

0407

Ulleval University Hospital, Oslo

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Helse Ost

UNKNOWN

collaborator

Ullevaal University Hospital

OTHER

collaborator

AstraZeneca

INDUSTRY

lead

Asker & Baerum Hospital

OTHER